Trials / Completed
CompletedNCT03560817
Survey of Health Preferences in Cancer Patients (QALY-Cancer)
Survey of Health Preferences in Cancer Patients: a Study Protocol for a Prospective, Longitudinal Cohort Using Online Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 198 (actual)
- Sponsor
- Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate health utilities in patients with breast or colorectal cancer.
Detailed description
The cost-utility analysis (CUA) is an increasingly used method to help health decision-maker. The CUA uses the Quality Adjusted Life Years (QALY) that combines the length of life with the health related quality of life (HRQoL) into a single score. In Quebec, no QALY calculation tool has been adapted to its linguistic and socio-cultural context, neither for its general population nor for a particular subpopulation, like patients with cancer. The objectives will be to analyze the extent of the divergence in terms of health states utilities between the general population and patients with breast or colorectal cancer; to develop a QALY preference weights dataset for patients with cancer; to perform "mapping" with different health-related quality of life questionnaires by correlating SF6Dv2 with EQ-5D-5L, EORTC QLQ-C30 and FACT- G. The data will be collected with a self-administered online survey. Patients outcomes will be measured at the beginning of the chemotherapy treatment cycle and about 8 days after the start of chemotherapy. Health utilities will be measured with a hybrid method using the time-trade-off (TTO) and the discrete experimental choice (DCE) method using SF6Dv2 questionnaire for health states.
Conditions
Timeline
- Start date
- 2017-01-04
- Primary completion
- 2019-06-28
- Completion
- 2019-06-28
- First posted
- 2018-06-18
- Last updated
- 2019-08-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03560817. Inclusion in this directory is not an endorsement.